The development and validation of a prediction model for post-AKI outcomes of pediatric inpatients

Chao Zhang1, Xiaohang Liu1, Ruohua Yan1

  • 1Department of Clinical Epidemiology and Evidence-based Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children Health, Beijing, China.

Clinical Kidney Journal
|February 24, 2025
PubMed

Insights

A new prediction model accurately identifies hospital mortality and dialysis risk in children with acute kidney injury (AKI). This tool aids early detection and management of pediatric AKI patients.

Area of Science:

  • Pediatric Nephrology
  • Clinical Informatics
  • Biostatistics

Background:

  • Acute kidney injury (AKI) is a frequent complication in hospitalized children.
  • Early detection of AKI outcomes is crucial for timely intervention in pediatric patients.
  • A predictive model can facilitate proactive management strategies for pediatric AKI.

Purpose of the Study:

  • To develop and validate a prediction model for post-acute kidney injury (AKI) outcomes in hospitalized children.
  • To assess the model's ability to predict hospital mortality and the need for dialysis within 28 days of AKI onset.
  • To compare the model's performance against the Pediatric Critical Illness Score (PCIS) for mortality risk stratification.

Main Methods:

  • Retrospective analysis of 8205 pediatric AKI cases from two Chinese hospitals.
  • Genetic Algorithm for feature selection and Random Forest model development.
  • Temporal and external validation of the prediction model's performance.

Main Results:

  • The model demonstrated high accuracy in predicting hospital mortality (AUROC 0.854) and dialysis (AUROC 0.889).
  • Performance remained robust across temporal and external validation datasets.
  • The proposed model significantly outperformed the PCIS in predicting mortality risk.

Conclusions:

  • The developed post-AKI outcomes prediction model shows significant potential for clinical application.
  • This model can aid in identifying high-risk pediatric AKI patients for targeted interventions.
  • Further implementation and validation in diverse clinical settings are warranted.
Abstract